47 results about "Tendonitis" patented technology

This invention provides for using a locally delivered low dose of a corticosteroid to treat pain caused by any inflammatory disease including sciatica, herniated disc, stenosis, mylopathy, low back pain, facet pain, osteoarthritis, rheumatoid arthritis, osteolysis, tendonitis, carpal tunnel syndrome, or tarsal tunnel syndrome. More specifically, a locally delivered low dose of a corticosteroid can be released into the epidural space, perineural space, or the foramenal space at or near the site of a patient's pain by a drug pump or a biodegradable drug depot.

A low cost foldable orthosis for the treatment of foot and ankle conditions including plantar facitis and tendonitis, the orthosis is a foldable molded portion manufactured in a variety of incremental sizes, having a generally U-shaped cross-sectional configuration and a flat foot bed, interconnected by a hinge. This device includes a variety of spacers which enable the angle of covered by a soft fabric covering, and using a removable and interchangeable foot bed wedge insert permitting the angle of dorsiflexion, plantar flexion, inversion and eversion to be varied.

A device for treatment of plantar fasciitis and/or Achilles tendonitis that comprises:

• (a) a calf strap removably engagable to the calf of a leg;
• (b) a foot assembly removably engagable to the foot of the leg such that when the device is worn the assembly can be positioned proximate to the ball of the foot intermediate to the midfoot and forefoot areas of the foot to secure it to the foot; and
• (c) a substantially inelastic tension member connectable between the calf strap and the foot assembly in a tensioned manner

such that when the device is worn the plantarflexion of the ankle is limited such that the plantar surface of the foot is held in a neutral to slight dorsiflection.

Also, a method of treating plantar fasciitis and/or Achilles tendonitis that comprises applying a such a device so as to maintain the plantar fascia and other structures on the plantar surface of the foot in a neutral to slight dorsiflection.

Provided is an ankle supporter capable of returning the wearer's ankle to a normal position by moving the connective tissue and muscles below the skin following sprain or Achilles tendonitis. The ankle supporter includes a first elastic panel knitted in a belt-like shape on the medial side of the wearer's foot extending from the sole to an area corresponding to the Achilles tendon and having a stretch resistance greater than that of the base fabric and a second elastic panel knitted in a belt-like shape on the medial side of the wearer's foot extending from the heel to the base of the foot top of the wearer to intersect the first elastic panel below the center of the medial ankle and having a stretch resistance greater than that of the base fabric.

The present disclosure is directed to modulators of cyclooxygenase (COX) enzymes and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the medical use of such compounds for the treatment and/or management of the severity and duration of non-specific pain, tension-type pain, headache, migraine, lower back pain, sciatica, dental pain, muscular pain, pain associated with acute soft tissue injuries, bursitis, tendonitis, lumbago, periarthritis, tennis elbow, sprains, strains, muscular problems associated with sports injuries, muscular problems associated with accidents, period pain, primary dysmenorrhoea, acute sore throat pain, osteoarthritis, rheumatoid arthritis, cancer, any disorder requiring analgesic response, any disorder requiring anti-inflammatory response, any disorder requiring antipyretic response, any conditions mediated by cyclooxygenase, cystic fibrosis, dementia, Alzheimer's disease, and/or conditions mediated by levels of β-amyloid are described.

The present invention is related to a bilayer pharmaceutical composition comprising naproxen or a pharmaceutically acceptable salt thereof. The present invention is particularly related to a bilayer pharmaceutical composition comprising an immediate release component and a controlled release component of naproxen or a pharmaceutically acceptable salt thereof and the process for preparation thereof. Moreover, the present invention is related to the treatment of rheumatoid arthritis, oesteoarthritis, ankylosing spondylitis, pain, primary dysmenorrhoea, acute tendinitis, bursitis and acute gout.

The present invention generally relates to transdermal drug delivery systems. More particularly, the present invention provides compositions and transdermal drug delivery systems for the treatment and/or relief of symptoms associated with carpal tunnel syndrome or tendonitis.

Analgesic formulations to be applied topically that are reported to relieve moderate to severe pain due to tendonitis, fibromyalgia, shingles, insect bites and bee stings, ACL, arthritis, and sinus headaches. In many cases, test subjects report immediate pain relief with a single application and complete pain elimination with only a few applications. The formulations are in a coconut oil base which is skin friendly. The primary active ingredient is wrightia tinctoria, which when combined with other ingredients, causes the formulation to exhibit a synergistic effect on pain relief unexpected from using the ingredients alone or in combination.

This invention provides compositions and methods for preventing inflammatory diseases of the joints, including rheumatoid and osteoarthritis, tendonitis, bursitis, inflammation of the ligament, synovitis, gout, and systemic lupus erythematosus, wherein the methods include injecting into the inflamed joint a therapeutic anti-inflammatory composition comprising a bacterial or viral IL-10 expression construct, wherein the IL-10 expression construct comprises a bacterial or viral backbone and a nucleic acid sequence encoding interleukin-10.

The present invention relates to novel urea and thiourea compounds, compositions comprising urea or thiourea compounds, and methods useful for treating and preventing aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, enhancing bile production, enhancing reverse lipid transport, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, modulating C reactive protein, obesity, oxysterol elimination in bile, pancreatitis, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), a thrombotic disorder, gastrointestinal disease, irritable bowel syndrome (IBS), inflammatory bowel disease (e.g., Crohn's Disease, ulcerative colitis), arthritis (e.g., rheumatoid arthritis, osteoarthritis), autoimmune disease (e.g., systemic lupus erythematosus), scleroderma, ankylosing spondylitis, gout and pseudogout, muscle pain: polymyositis/polymyalgia rheumatica/fibrositis; infection and arthritis, juvenile rheumatoid arthritis, tendonitis, bursitis and other soft tissue rheumatism. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

There is provided an arch strap suitable for the treatment of pain in a patient's heel, such as plantar fasciitis, posterior tibial tendonitis and capsulitis of the foot. The arch strap comprises a first portion serving as a pad, shaped and sized to fit under the arch beneath a patient's foot along the lateral portion of the foot from the fifth metatarsal head to the back of the heel and extending upwardly along one side of the patient's foot to the medial portion of the foot. The first portion is preferably adhesively attached to the arch of the foot and provides support and stability to the foot when properly positioned on a patient. There is an elongated strip having a first end attached to one side of the first portion and extending around the patient's heel and positioned in the medial portion of the foot where it adhesively attaches to the foot. The elongated strip is preferably an adhesive elastic tape such as Elastoplast® elastic adhesive bandage. The elongated strip serves to keep the first portion in place and to provide support in the patient's heel to relieve pain. There is also provided a method for using the heel pain strap.

The invention discloses an external power used for dredging collaterals and strengthening bones, which is prepared from traditional Chinese medical materials according to the following weight percentages: 1 percent to 5 percent of unprepared nux vomica, 10 percent to 40 percent of unprepared white mustard seeds, 5 percent to 15 percent of unprepared radix aconite, 5 percent to 15 percent of unprepared radix aconiti agrestis, 2 percent to 15 percent of herba asari, 3 percent to 11 percent of rhizoma arisaematis, 8 percent to 13 percent of radix clematidis, 1 percent to 4 percent of camphor, 1.8 percent to 3.1 percent of borneol, 0.6 percent to 0.9 percent of cantharis, 0.12 percent to 7 percent of angelica root, 0.01 percent to 0.04 percent of musk, 0.1 percent to 3.2 percent of unprepared frankincense and 1 percent to 3.2 percent of unprepared myrrh. The powder is mixed with boiled water to form a paste and taken when not hot. The power is mainly used for treating rheumatoid arthritis, atrophic arthritis, protrusion of intervertebral disc, sciatica, hyperostosis in parts of human body, scapulohumeral peri arthritis, tendonitis numb and other diseases, and is testified by the clinical applications to have quick effect and good curative effect.

The invention discloses a traditional Chinese medicine fumigation lotion for treating achilles tendonitis and a preparation method thereof, and belongs to the field of traditional Chinese medicines. The active components of the medicine provided by the invention comprise the following raw materials: radix et folium psychotriae serpentis, radix et caulis ventilaginis leiocarpae, radix uncariae rhynchophyllae, radix salviae miltiorrhizae, elatostema stewardii merr, caulis kadsurae, herba goodyerae, rhizoma polygoni cuspidati, herba ainsliaea albo-tomentosae, herba tetrastigmatis obtecti, cortex acanthopanacis, radix glycyrrhizae, radix seu caulis kadsurae heteroclitae, cortex schefflerae octophyllae, radix cynoglossi amabilis, rhizoma ligustici chuanxiong, fructus foeniculi, dioscorea tenuipes, daphne koreana nakai, cinnamomum tamala, wikstroemia canescens, rhizoma et radix smilacis nipponicae, radix et folium murrayae and borneolum syntheticum. The traditional Chinese medicine fumigation lotion selects medicinal materials conforming to the principles of monarch, minister, assistant and guide, is applied according to cause of disease, has effects of dispelling wind and eliminating dampness, warming the meridians and dredging blood vessel, promoting blood circulation to remove blood stasis, promoting qi to activate blood circulation, reducing swelling and resolving mass, relaxing tendons and activating collaterals, strengthening the muscles and bones, and promoting circulation of qi to relieve pain, can effectively relieve pain, promotes blood circulation, accelerate tissue repair, has good absorption effect, obvious treatment effect, no toxic and side effects and no adverse clinical reactions, and is clinically proven to have high cure rate for achilles tendonitis.

Effective treatments of pain and/or inflammation from tendonitis, carpal tunnel syndrome, tarsal tunnel syndrome, osteoarthritis, bursitis and/or an oral-facial disease are provided. Through the administration of an effective amount of at least one alpha adrenergic agonist at or near a target site, one can reduce, prevent or treat pain and/or inflammation from tendonitis, carpal tunnel syndrome, tarsal tunnel syndrome, osteoarthritis, bursitis and/or an oral-facial disease.

A method of treating said musculoskeletal and connective tissue inflammations including osteoarthritis and associated articular and periarticular inflammations, and non-articular Rheumatism including capsulitis, tendonitis, fibrositis, and perarticular inflammations is disclosed. The method includes administering to a patient of a therapeutically effective amount of a composition comprising 13-cis-retinoic acid. Preferably, the treatment method includes administering to a patient of an initial dosage of a composition comprising 13-cis-retinoic acid for an initial treatment period, and thereafter administering a maintenance dosage of the composition.